Will Bainbridge

Will Bainbridge is a strategic leader known for driving growth and transformations in various companies, spanning start-ups to established ones.

He has a proven track record of turning around underperforming assets into high-performing entities by taking calculated risks and fostering engaged teams.

With a background in US and Global commercial and operational leadership, Will has experience across the full business lifecycle, including start-up, growth, maturity, and turnaround phases.

His expertise includes new product development, roadmap creation, launches, digital transformation, and data optimization.

Will's skill set extends to M&A activities (both buy-side and sell-side), alliance management, and capital raising, with a focus on industries such as pharma (CV, Diabetes, CNS, Rare Disease, Autoimmune), medical devices (Class I, II, III), drug delivery, and technology (SaaS, AI, Cloud).

Education-wise, he attended Woodberry Forest School before pursuing Bachelor's degrees in English and German at Denison University.

In terms of professional experience, Will has held key roles such as Global Early Commercial Strategy Head for Bacterial Vaccines & Monoclonals at GSK.

He has also served as an independent consultant specializing in life sciences, pharma, and medtech consulting, in addition to contributing to commercial, marketing, managed care, and sales leadership functions within the pharma, biotech, and medtech digital sectors.